Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Shasun Chemicals and Drugs Limited
Shasun Chemicals and Drugs Limited
Activities:
Manufacturing
Ingredients
Research & Development
Trending Articles
Ariceum Therapeutics' radiopharmaceutical SCLC therapeutic receives FDA Orphan Drug Designation
The therapeutic candidate will enter into Phase I/II clinical trials in Q1 of 2025, and has shown significant promise in treating aggressive cancers such as SCLC in preclinical...
Mastering modified-release performance: excipient considerations
Imagine a world where enhanced therapeutic efficacy, improved patient compliance and reduced adverse effects are tangible outcomes — even for drugs with short pharmacokinetic...
BioMed X and Merck successfully complete ecDNA oncology research programme
The project looked at which genes impact the prevalence of extrachromosomal DNA in cancer cells, and how ecDNA influences the adaptability of these cells
Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription
With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence
Weight loss drugs boost big pharma earnings, says AvaTrade
This week pharmaceutical giants Eli Lilly and Novo Nordisk both released their financial results for the fourth quarter of 2024, showcasing major developments in their obesity...
Upcoming event
Pharma Packaging and Labelling Forum
5–6 March 2025 | Conference | San Diego, US
See all
Related Content
Finance
Strides Shasun acquires three OTC brands from Moberg Pharma
Indian firm is building an over-the-counter drug franchise in regulated and emerging markets
Pharmaceutical
Indian generic manufacturers aim to enter the Japanese market
The penetration of generic drugs in Japan is a little more than 30% compared with more 80% in the US market
Ingredients
Indian API market on the up as domestic drug prices fall
Indian API manufacturers are branching out into new markets, while international suppliers could be hit by lower prices in the domestic market, writes Asia correspondent A Nair
Ingredients
Indian pharma exports to be hit by Falsified Medicines Directive
API exporters say latest EU move is a non-issue
Subscribe now